Biblio

Export 178 results:
Author Title Type Year
Filters: Keyword is Animals  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Animals
N. Iwahara, Hisahara, S., Kawamata, J., Matsumura, A., Yokokawa, K., Saito, T., Fujikura, M., Manabe, T., Suzuki, H., Matsushita, T., Suzuki, S., and Shimohama, S., Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice., J Alzheimers Dis, vol. 55, no. 3, pp. 1235-1247, 2017.
L. - S. Liu, Bai, X. - Q., Gao, Y., Wu, Q., Ren, Z., Li, Q., Pan, L. - H., He, N. - Y., Peng, J., and Tang, Z. - H., PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway., J Alzheimers Dis, vol. 57, no. 3, pp. 723-734, 2017.
G. Marwarha, Rostad, S., Lilek, J., Kleinjan, M., Schommer, J., and Ghribi, O., Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation., J Alzheimers Dis, vol. 57, no. 3, pp. 907-925, 2017.
M. Romeo, Stravalaci, M., Beeg, M., Rossi, A., Fiordaliso, F., Corbelli, A., Salmona, M., Gobbi, M., Cagnotto, A., and Diomede, L., Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity., J Alzheimers Dis, vol. 57, no. 3, pp. 857-871, 2017.
Y. Huang, Shen, W., Su, J., Cheng, B., Li, D., Liu, G., Zhou, W. - X., and Zhang, Y. - X., Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity., J Alzheimers Dis, vol. 57, no. 3, pp. 885-897, 2017.
U. Rüb, Stratmann, K., Heinsen, H., Seidel, K., Bouzrou, M., and Korf, H. - W., Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches., J Alzheimers Dis, vol. 57, no. 3, pp. 683-696, 2017.
J. Cummings, Ritter, A., and Zhong, K., Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future., J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
S. Beggiato, Borelli, A. Celeste, Ferraro, L., Tanganelli, S., Antonelli, T., and Tomasini, M. Cristina, Palmitoylethanolamide Blunts Amyloid-β42-Induced Astrocyte Activation and Improves Neuronal Survival in Primary Mouse Cortical Astrocyte-Neuron Co-Cultures., J Alzheimers Dis, vol. 61, no. 1, pp. 389-399, 2018.
Y. Hasegawa, Toyama, K., Uekawa, K., Ichijo, H., and Kim-Mitsuyama, S., Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging., J Alzheimers Dis, vol. 61, no. 1, pp. 259-263, 2018.
J. Mehla, Lacoursiere, S., Stuart, E., McDonald, R. J., and Mohajerani, M. H., Gradual Cerebral Hypoperfusion Impairs Fear Conditioning and Object Recognition Learning and Memory in Mice: Potential Roles of Neurodegeneration and Cholinergic Dysfunction., J Alzheimers Dis, vol. 61, no. 1, pp. 283-293, 2018.
C. M. Huber, Yee, C., May, T., Dhanala, A., and Mitchell, C. S., Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy., J Alzheimers Dis, vol. 61, no. 1, pp. 265-281, 2018.
S. Gelman, Palma, J., Tombaugh, G., and Ghavami, A., Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 195-208, 2018.
K. Muthukumaran, Kanwar, A., Vegh, C., Marginean, A., Elliott, A., Guilbeault, N., Badour, A., Sikorska, M., Cohen, J., and Pandey, S., Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
J. Paulo Alme Santos, Vizuete, A., Hansen, F., Biasibetti, R., and Gonçalves, C. - A., Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 237-249, 2018.
C. - C. Tan, Zhang, X. - Y., Tan, L., and Yu, J. - T., Tauopathies: Mechanisms and Therapeutic Strategies., J Alzheimers Dis, vol. 61, no. 2, pp. 487-508, 2018.
T. Saksida, Koprivica, I., Vujičić, M., Stošić-Grujičić, S., Perović, M., Kanazir, S., and Stojanović, I., Impaired IL-17 Production in Gut-Residing Immune Cells of 5xFAD Mice with Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 61, no. 2, pp. 619-630, 2018.
B. M. Law, Guest, A. L., Pullen, M. W. J., Perkinton, M. S., and Williams, R. J., Increased Foxo3a Nuclear Translocation and Activity is an Early Neuronal Response to βγ-Secretase-Mediated Processing of the Amyloid-β Protein Precursor: Utility of an AβPP-GAL4 Reporter Assay., J Alzheimers Dis, vol. 61, no. 2, pp. 673-688, 2018.
C. D. Pereira, Martins, F., Wiltfang, J., Silva, O. A. B. da Cru, and Rebelo, S., ABC Transporters Are Key Players in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 463-485, 2018.
D. Brici, Götz, J., and Nisbet, R. M., A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles., J Alzheimers Dis, vol. 61, no. 3, pp. 899-905, 2018.
Y. Fan, Luo, R., Su, L. - Y., Xiang, Q., Yu, D., Xu, L., Chen, J. - Q., Bi, R., Wu, D. - D., Zheng, P., and Yao, Y. - G., Does the Genetic Feature of the Chinese Tree Shrew (Tupaia belangeri chinensis) Support Its Potential as a Viable Model for Alzheimer's Disease Research?, J Alzheimers Dis, vol. 61, no. 3, pp. 1015-1028, 2018.
H. P Reddy, Manczak, M., Yin, X. L., Grady, M. Catherine, Mitchell, A., Tonk, S., Kuruva, C. Sekhar, Bhatti, J. Singh, Kandimalla, R., Vijayan, M., Kumar, S., Wang, R., Pradeepkiran, J. Adi, Ogunmokun, G., Thamarai, K., Quesada, K., Boles, A., and Reddy, A. P., Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
A. Ishikawa, Tokunaga, M., Maeda, J., Minamihisamatsu, T., Shimojo, M., Takuwa, H., Ono, M., Ni, R., Hirano, S., Kuwabara, S., Ji, B., Zhang, M. - R., Aoki, I., Suhara, T., Higuchi, M., and Sahara, N., In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510., J Alzheimers Dis, vol. 61, no. 3, pp. 1037-1052, 2018.
O. M. Volpina, Samokhin, A. N., Koroev, D. O., Nesterova, I. V., Volkova, T. D., Medvinskaya, N. I., Nekrasov, P. V., Tatarnikova, O. G., Kamynina, A. V., Balasanyants, S. M., Voronina, T. A., Kulikov, A. M., and Bobkova, N. V., Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice., J Alzheimers Dis, vol. 61, no. 3, pp. 1061-1076, 2018.
A. Arner, Rockenstein, E., Mante, M., Florio, J., Masliah, D., Salehi, B., Adame, A., Overk, C., Masliah, E., and Rissman, R. A., Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau., J Alzheimers Dis, vol. 61, no. 3, pp. 1201-1219, 2018.
J. A. Snir, Suchy, M., Bindseil, G. A., Kovacs, M., Chronik, B. A., Hudson, R. H. E., Pasternak, S. H., and Bartha, R., An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 61, no. 3, pp. 1241-1252, 2018.

Pages